2 chapters across the catalog
The FDA's oversight of foreign drug plants is criticized for being ineffective, as inspectors often provide months of advance notice before visiting facilities in India and China. This allows companies to employ "data falsification teams" to scrub records and fabricate safety results. The system is described as a global scam that prioritizes the "money train" over public health.
Harvard behavioral psychologist Marc Hauser resigned following an inquiry into the falsification of data in his research on monkeys. The hosts find the New York Times coverage of the story vague and "screwy," noting that the specific nature of his wrongdoing was not clearly explained. They question why mundane research on baboons would lead to such a high-profile scandal.
